Highlights Johnson & Johnson BOERSE MUENCHEN

Equities

JNJ

US4781601046

Market Closed - BOERSE MUENCHEN Other stock markets 15:54:03 2024-06-14 EDT			5-day change	1st Jan Change
135.7 ^EUR	+0.27%		-0.29%	-4.17%

06-15	Johnson & Johnson Announces Late-Breaking Results Show nipocalimab Significantly Improves Sjögren's Disease Activity in A Phase 2 Study	CI
06-14	EU regulator mandates label updates on CAR-T cancer therapies	RE

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Johnson & Johnson Announces Late-Breaking Results Show nipocalimab Significantly Improves Sjögren's Disease Activity in A Phase 2 Study	06-15	CI
EU regulator mandates label updates on CAR-T cancer therapies	06-14	RE
J&J: encouraging trial in relapsing multiple myeloma	06-14	CF
J&J: the promise of ibrutinib in CLL	06-14	CF
J&J: promising results for Imbruvica in leukemia	06-14	CF
Johnson & Johnson Reports Positive Long-Term Results for Talvey in Multiple Myeloma Study	06-14	MT
Johnson & Johnson Announces TALVEY® (Talquetamab-Tgvs) Demonstrates Highly Durable, Longer-Term Responses in Patients with Relapsed or Refractory Multiple Myeloma	06-14	CI
High-risk health workers can get routine Ebola vaccine, Gavi says	06-13	RE
Xencor to Regain Exclusive Global Rights to CD20 x CD3 Bispecific T-Cell Engager	06-13	MT
High-risk health workers can get routine Ebola vaccine, says Gavi	06-13	RE
Cancer victims ask court to block J&J talc bankruptcy	06-12	RE
Sector Update: Health Care Stocks Softer Late Afternoon	06-11	MT
Johnson & Johnson to Pay $700 Million in Talc Case Settlement With 43 State Prosecutors	06-11	MT
J&J Talcum-Settlement Consent Judgments Filed, U.S. State AGs Say	06-11	DJ
RTW Biotech portfolio company to sell subsidiary for USD1.25 billion	06-11	AN
Top law firms in US opioid lawsuits to get hundreds of millions in fees	06-07	RE
J&J-backed Rapport Therapeutics shares debut nearly 6% higher	06-07	RE
J&J: FDA approves VELYS for knee arthroplasty	06-07	CF
J&J-backed Rapport Therapeutics raises $136 mln in US IPO	06-06	RE
Global markets live: ASML, Intel, Microsoft, Tesla, J&J, Gitlab	06-04

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 12:30 pm